FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Ellins Craig
2. Issuer Name and Ticker or Trading Symbol

GB SCIENCES INC [ GBLX ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Chief Innovation Officer
(Last)          (First)          (Middle)

3035 EAST PATRICK LANE, SUITE 9
3. Date of Earliest Transaction (MM/DD/YYYY)

3/2/2017
(Street)

LAS VEGAS, NV 89120
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   3/2/2017     S    74207   D $0.3482   2845793   D    
Common Stock   3/3/2017     S    25793   D $0.3483   2820000   D    
Common Stock   3/7/2017     S    35000   D $0.3577   2785000   D    
Common Stock   3/8/2017     S    65000   D $0.3477   2720000   D    
Common Stock   3/9/2017     S    100000   D $0.3292   2620000   D    
Common Stock   3/10/2017     S    25000   D $0.328   2595000   D    
Common Stock   3/13/2017     S    30000   D $0.3277   2565000   D    
Common Stock   3/14/2017     S    25000   D $0.3283   2540000   D    
Common Stock   3/15/2017     S    50000   D $0.3247   2490000   D    
Common Stock   3/16/2017     S    50000   D $0.3291   2440000   D    
Common Stock   3/20/2017     S    11810   D $0.3247   2428190   D    
Common Stock   3/21/2017     S    16630   D $0.3131   2411560   D    
Common Stock   3/27/2017     S    10800   D $0.304   2400760   D    
Common Stock   3/28/2017     S    12200   D $0.3114   2388560   D    
Common Stock   3/29/2017     S    21500   D $0.3304   2367060   D    
Common Stock   3/30/2017     S    15313   D $0.3201   2351747   D    
Common Stock   4/3/2017     S    27544   D $0.3365   2324203   D    
Common Stock   4/4/2017     S    20000   D $0.3344   2304203   D    
Common Stock   4/5/2017     S    34633   D $0.3162   2269570   D    
Common Stock   4/6/2017     S    8742   D $0.3053   2260828   D    
Common Stock   4/7/2017     S    10000   D $0.2971   2250828   D    
Common Stock   4/10/2017     S    32100   D $0.3082   2218728   D    
Common Stock   4/11/2017     S    32100   D $0.2928   2186628   D    
Common Stock   4/17/2017     S    16068   D $0.3095   2170560   D    
Common Stock   4/18/2017     S    16068   D $0.294   2154492   D    
Common Stock   4/24/2017     S    7214   D $0.3012   2147278   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Ellins Craig
3035 EAST PATRICK LANE
SUITE 9
LAS VEGAS, NV 89120
X
Chief Innovation Officer

Signatures
/s/ Craig Ellins 6/16/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
GB Sciences (PK) (USOTC:GBLX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more GB Sciences (PK) Charts.
GB Sciences (PK) (USOTC:GBLX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more GB Sciences (PK) Charts.